Is there a difference in the cerebral vascular response to rebreathing-induced hypercapnia between obese and lean individuals? r What is the main finding and its importance?
Introduction
Obesity increases cardiovascular disease morbidity and mortality by >45% and is a contributing factor in 13% of all deaths occurring in the USA (Daviglus et al. 2004) . Although the underlying mechanisms have not yet been clarified, endothelial dysfunction is a major contributing factor (Perticone et al. 2001) . Endothelial dysfunction also attenuates cerebral vascular function, which impairs cerebral blood flow (CBF) regulation (Zimmermann & Haberl, 2003; Lavi et al. 2006) . In this regard, obesity contributes to a variety of cerebral vascular diseases and conditions including stroke, Alzheimer's disease, dementia and cognitive impairment (Gustafson et al. 2003; Gorospe & Dave, 2007; Mozaffarian et al. 2015) .
The cerebral vasculature is tightly regulated by arterial carbon dioxide tension (P aCO 2 ) such that, in normal physiological conditions, hypercapnia increases CBF, whereas hypocapnia decreases CBF Willie et al. 2014) . The relationship between changes in CBF and/or cerebral vascular conductance (CVCI) in response to changing P aCO 2 provides an index of cerebral vascular function (Ringelstein et al. 1988; Kleiser & Widder, 1992) . The increase in CBF and/or CVCI during hypercapnia represents an index of cerebral vascular function and occurs primarily through modulation of the cerebral microcirculation and thus provides a non-invasive index of cerebral vascular health (Ringelstein et al. 1988; Lavi et al. 2003) . Cerebral vascular reactivity is diminished in a number of clinical conditions, including diabetes (Kadoi et al. 2003) , hypertension (Lavi et al. 2006) and carotid artery disease (Ringelstein et al. 1988) , and is a predictor and contributor to stroke (Nur et al. 2009 ). Importantly, impaired endothelial function blunts vasodilatation in the cerebral vasculature, leading to a dysfunction in CBF regulation (Zimmermann & Haberl, 2003; Lavi et al. 2006) .
Although obesity is a contributing factor to a number or disease conditions, including various forms of heart disease, systemic hypertension, metabolic syndrome and type II diabetes (Mozaffarian et al. 2015) , the effect of obesity on cerebral vascular reactivity to carbon dioxide is less known, particularly in a relatively young and otherwise healthy cohort of individuals. Accordingly, in this study we tested the hypothesis that cerebral vascular reactivity, as assessed by rebreathing-induced hypercapnia, is attenuated in healthy young obese individuals relative to age-matched lean counterparts.
Methods

Ethical approval
The Institutional Review Board at The University of Texas at Austin approved all study procedures and the consent process (approval no. 2011-05-0029) . Subjects were given a verbal description of all procedures and informed of the purpose and risks involved in the study before providing their informed, written consent. The study conformed to the standards set by the Declaration of Helsinki (apart from registration in a data base).
Subjects
Sixteen lean (nine males) and 15 obese subjects (seven males) participated in this study. Lean and obese subjects were classified as having a body mass index <25 and >30 kg m −2 , respectively. All subjects were non-smokers, were not taking medications and were free from cardiovascular, neurological, metabolic or cognitive disease. All studies were conducted in a temperature-controlled laboratory (ß24°C and 40% relative humidity) in the morning, following an overnight fast (>12 h) and after refraining from strenuous activity and alcohol for a minimum of 24 h. Ethnicity was matched between groups because this is a contributing factor to attenuated cerebral vascular response to hypercapnia (Hurr et al. 2015a,b) .
Instrumentation and measurements
Data were collected in the supine position. Each subject was instrumented for continuous measurement of heart rate (HR) and cardiac rhythms from an electrocardiogram (HP Patient Monitor; Agilent, Santa Clara, CA, USA) interfaced with a cardiotachometer (CWE, Ardmore, PA, USA). Mean arterial pressure (MAP) was continuously monitored from a finger using the Penaz method (Biopac Monitor 500; CNAP, Bruck an der Mur, Austria). The velocity of CBF (CBV) was continuously measured using transcranial Doppler ultrasonography. A 2 MHz Doppler probe (Multi-flow; DWL Elektronische Systeme, Singen, Germany) was adjusted over the temporal window of the right middle cerebral artery (MCA) until an optimal signal was identified. Cerebral vascular conductance (CVCI) was calculated as the ratio of CBV to MAP. The end-tidal carbon dioxide tension (P ET,CO 2 ) was continuously measured through a mouthpiece using a capnograph (VitalCap Capnograph Monitor; Oridion, Needham, MA, USA).
Experimental protocol
After instrumentation, subjects rested quietly for a minimum of 20 min. Subjects were then fitted with a nose clip and breathed room air through a mouthpiece attached to a Y-valve, one end of which was connected to a 5 litre bag, whereas the other end was open to room air. Subjects breathed room air for 6 min of baseline data collection while CBV, MAP, HR and P ET,CO 2 were continuously collected. Subjects then performed the rebreathing protocol as previously described (Brothers et al. 2014; Hurr et al. 2015a,b) . Briefly, they first performed a deep inspiration, upon which the Y-valve was switched so that they inspired into and expired out of the 5 litre bag. After ß3 min of rebreathing, the valve was switched once again, allowing them to breathe room air for a recovery period. During the rebreathing protocol, arterial oxygen saturation was continuously monitored by pulse oximetry (Covidien; Atlanta, GA, USA) and was held constant (between 97 and 98%) by bleeding a small amount of oxygen into the rebreathing bag that was individually calculated based on each individual's basal metabolic rate as estimated using the Harris-Benedict formula (Claassen et al. 2007; Brothers et al. 2014; Hurr et al. 2015a,b) .
Data analysis
The MAP, HR, CBV and P ET,CO 2 were collected at 125 Hz via a data-acquisition system (Biopac Systems Inc., Santa Barbara, CA, USA). Average values for P ET,CO 2 , CBV, MAP and CVCI were determined throughout the last 1 min of baseline and then on a breath-by-breath basis during rebreathing. The percentage change in CVCI from baseline was determined, and the absolute change in P ET,CO 2 over the entire rebreathing protocol was assessed. The MAP was averaged over the first three and last three respiratory cycles during rebreathing. The difference between the last three and the first three cycles was calculated to assess the magnitude of change in MAP during hypercapnia. The relationship between CBF and P ET,CO 2 is sigmoidal, so a four-parameter logistic regression was used for non-linear curve fitting (Claassen et al. 2009; Hurr et al. 2015a,b) , as follows:
where a represents the range of change in percentage CVCI, b represents the overall sigmoidal property of the curve, x0 is the level of P ET,CO 2 at which cerebral vascular reactivity is maximal [i.e. maximal cerebral vascular reactivity (CVMR)], and y0 represents the maximal value of percentage CVCI achieved during rebreathing (Fig. 1A ).
Statistical analysis
Statistical analyses were performed using a statistical software package (SigmaPlot 12.5; Systat Software, Inc., San Jose, CA, USA). Subject characteristics, baseline haemodynamic data and all parameters from the four-parameter logistic regression were compared using Student's two-tailed paired t tests within individuals in each group or Student's two-tailed unpaired t test between the two groups. A χ 2 test was used for differences in sex and ethnicity between the two groups. All significance A, a logistic regression curve and four parameters of cerebral vascular conductance index (CVCI) versus the partial pressure of end-tidal carbon dioxide (P ET,CO 2 ). The parameter a represents the total range of change in the percentage of CVCI, b is a constant that determines the overall sigmoidal property of the curve, x0 is the level of P ET,CO 2 at which the cerebral vasomotor reactivity (i.e. slope) for CVCI is maximal [i.e. maximal cerebral vascular reactivity (CVMR)], and y0 represents the maximal CVCI value during the hypercapnia. B, the changes in CVCI with increase in P ET,CO 2 for an obese (filled circles) and a lean subject (open circles). The magnitude of increase in CVCI was blunted in the obese individual relative to the lean counterpart. Impact of body weight on control of brain blood flow was set at P < 0.05, and data are presented as means ± SD.
Results
Subject characteristics and baseline haemodynamic values
The two groups were well matched for age, sex, race and height (Table 1 ; P > 0.05 for all comparisons). By design, the obese group had a greater weight and body mass index (P < 0.001 for both comparisons). In addition, plasma triglycerides were higher and plasma high-density lipoprotein concentration was lower in obese subjects (Table 1 ; P < 0.05 for both comparisons). During eucapnic baseline, there were no differences between groups for MAP, CBV or P ET,CO 2 (Table 2 ; P > 0.05 for all comparisons); however, HR was higher and CVCI lower in obese individuals at baseline (Table 2 ; P < 0.05 for each). Table 3 illustrates that the magnitude of hypercapnia ( P ET,CO 2 ) induced by the rebreathing protocol was similar between groups (Table 3 ; P = 0.82), whereas the increase in MAP and HR during rebreathing was greater in the obese relative to the lean subjects (Table 3 ; P < 0.01).
Cerebral vascular responses during hypercapnia
The maximal CBF achieved during hypercapnia, indexed as a percentage of baseline CBV, was similar between groups (Table 3 ; P = 0.29). In contrast, the maximal CVCI achieved during hypercapnia, as a percentage of baseline, was reduced in the obese relative to the lean subjects (Table 3 ; P < 0.01).
Curve fitting and model parameters
The total range of change in CBV during rebreathing (a; expressed as a percentage) was similar between groups (Table 3 and Fig. 2A ; P = 0.07). In contrast, the total range of change in CVCI during rebreathing (a; expressed as a percentage) was attenuated in the obese relative to the lean individuals (Table 3 and Fig. 2A ; P < 0.01). Likewise, the maximal increase in CBV during rebreathing (y0; expressed as a percentage) was similar between groups (Table 3 and Fig. 2B ; P = 0.20). In contrast, the maximal increase in CVCI during rebreathing (y0; expressed as a percentage) was attenuated in the obese relative to the lean individuals (Table 3 and Fig. 2B ; P = 0.01).
The degree of hypercapnia that elicited that greatest CO 2 sensitivity for CBV and CVCI (x0; in millimetres of mercury) was not different between groups (Table 3 ; P > 0.05 for each comparison). Estimates of maximal CVMR achieved during rebreathing for CBV and CVCI were similar between groups (Table 3 ; P = 0.77 and 0.40, respectively).
Discussion
The primary finding of the present investigation is that the cerebral vasodilator response, indexed as the increase in cerebral vascular conductance, to rebreathing-induced hypercapnia is attenuated in obese individuals compared with their lean counterparts. Little is known regarding the relationship between obesity and cerebral vascular health, particularly in a relatively young population free of any underlying cardiovascular or metabolic disease. Given that excessive body weight is associated with various diseases and conditions, including stroke, dementia, cognitive dysfunction and Alzheimer's disease (Gustafson et al. 2003; Gorospe & Dave, 2007) , reduced cerebral vascular function, indexed as attenuated cerebral vascular reactivity and thus vasodilatation during hypercapnia, might represent a possible underlying mechanism for the higher prevalence of these aforementioned conditions in this population. Abbreviations: a, the range of changes in percentage of CBV or CVCI; b, a constant that determines the overall sigmoidal property of the curve; CBV, velocity of blood in the middle cerebral artery; CVCI, index of cerebral vascular conductance; CVMR, maximal cerebral vascular reactivity; HR, heart rate; MAP, mean arterial pressure; P ET,CO 2 , partial pressure of end-tidal carbon dioxide; x0, the level of P ET,CO 2 at which cerebral vasomotor reactivity for CBV or CVCI is maximal; and y0, the maximal value of CBV and CVCI during the hypercapnic rebreathing protocol. Values are means (SD).
C. Hurr and others
Cerebral vascular response to hypercapnia
In the cerebral vasculature, carbon dioxide plays an important regulatory role in order to ensure an adequate nutrient and oxygen supply to the brain tissue and removal of metabolic waste products from the brain tissue (Ringelstein et al. 1988; Kleiser & Widder, 1992) . The ability of the brain to respond to changes in P aCO 2 is an indicator of overall cerebral vascular health (Ringelstein et al. 1988; Kleiser & Widder, 1992) . Patients with hypertension, carotid artery disease and/or Alzheimer's disease have an impaired cerebral vascular response to changes in CO 2 (Ringelstein et al. 1988; Silvestrini et al. (Kleiser & Widder, 1992) . The findings of an attenuated cerebral vasodilator response to hypercapnia in the obese cohort are similar to recent observations from our laboratory indicating a similar impairment during hypercapnia in college-aged African Americans; another population with elevated metabolic, cardiovascular and cerebral vascular disease risk (Hurr et al. 2015a,b) . They do, however, conflict with a previous report of preserved hypercapnia-induced increase in CVCI in a group of obese adults with metabolic syndrome (Harrell et al. 2013) . Other than the use of a different cohort of subjects and different methods of inducing hypercapnia (i.e. steady state versus rebreathing), another possible explanation for the discrepancy in findings could be related to the degree of hypercapnia used in the two studies. For example, the magnitude of hypercapnia in the study by Harrell et al. (2013) was lower than in the present study ( 10 versus 15 mmHg). In the present study, the percentage CVCI increased during hypercapnia in a similar fashion in both groups during the first 10 mmHg increase in P ET,CO 2 (data not shown). However, further elevation in the percentage CVCI was restricted only in the obese subjects during the last 4-5 mmHg increase in P ET,CO 2 (see Fig. 1B for a representative example). In contrast, lean subjects showed a relatively linear relationship between P ET,CO 2 and percentage CVCI throughout the entire range (see Fig. 1B for a representative example) .
The reduction in both the range of change in CVCI (a) and the maximal CVCI (y0) in obese relative to lean individuals was not observed with CBV (velocity data in Fig. 2A and B) . The difference between CVCI and CBV appears to be attributable to a different pressor response to hypercapnia between the two groups, the magnitude of which was greater in the obese individuals (Table 3) . In other words, it is likely that the greater blood pressure response in the obese individuals is a compensatory response for impaired ability of the cerebral vascular to vasodilate during the hypercapnic challenge, as has been demonstrated in the peripheral vasculature in this population during various perturbations (Perticone et al. 2001; Meyer et al. 2006) . This augmented response would generate a greater pressure head, which would result in maintained flow, indexed as blood velocity in the middle cerebral artery in the present investigation. This suggests that the earlier onset of a plateau observed in the percentage CVCI, despite a greater blood pressure response and thus 'drive' for CBV, is related to an increased drive for cerebral vasoconstriction or impaired cerebral vasodilatory capacity or cerebral endothelial function (or some combination of both) in the obese individuals. In support of this increased vasoconstriction hypothesis, obese individuals have a greater degree of sympathetic activation during hypercapnia relative to their lean counterparts (Narkiewicz et al. 1999) . Although the role of the sympathetic nerve activity in the regulation of the cerebral vasculature remains a topic of debate, it is possible that the blunted cerebral vasodilatory response could be attributed to an augmented hypercapnia-induced activation of the sympathetic nerve activity in the obese cohort.
Cerebral blood flow is tightly regulated by changes in CO 2 as well as by changes in shear stress and arterial blood pressure. As mentioned above, the preserved CBV response in the obese cohort appears to be related to an augmented pressor response relative to the lean individuals, whereas the attenuated CVCI response (i.e. cerebral vascular reactivity) can result from endothelial dysfunction or an impairment in the mechanisms leading to CO 2 -mediated vasodilatation. Inhibition of nitric oxide synthase (NOS) reduces CBF in resting conditions (Joshi et al. 2000) . The increase in CBF during hypercapnia was completely blocked after NOS inhibition in humans (Schmetterer et al. 1997) and in various animal models (Thompson et al. 1996) , and the effect of NOS inhibition increased in a hypercapnia-dependent manner (Buchanan & Phillis, 1993) , which also suggests a relationship between NO bioavailability and cerebral vascular responsiveness during hypercapnia. This is further supported by data demonstrating that infusion of L-arginine, a substrate required for NO synthesis by NOS, into the carotid arteries improves cerebral vasodilatory capacity during hypercapnia in an animal model (Thompson et al. 1996) as well as in humans with elevated cerebral vascular risk (Zimmermann & Haberl, 2003) . Patient populations with known impairments in peripheral endothelial function also have an impaired CBF response to hypercapnia (Ringelstein et al. 1988; Kadoi et al. 2003; Lavi et al. 2006; Nur et al. 2009) , and this impairment is attenuated after administration of the exogenous NO donor sodium nitroprusside (Lavi et al. 2006) . Collectively, these data provide evidence for a link between NO bioavailability and endothelial function and the subsequent increase in CVCI during hypercapnia. In this regard, overweight and obese individuals have blunted endothelium-dependent vasodilatation in their brachial and femoral arteries in response to acetylcholine, methacholine, bradykinin or shear stress, which suggests a decrease in NO production or bioavailability or both in this population (Perticone et al. 2001; Meyer et al. 2006) . These impairments could contribute to the reduced cerebral vascular reactivity to carbon dioxide in this population. Another possibility could be linked to the lower plasma high-density lipoprotein and higher plasma triglycerides (Table 1) , both known cardiovascular disease risk factors, in the obese cohort. Excess adipose tissue causes dyslipidaemia, increased inflammation and oxidative stress, thereby contributing to endothelial dysfunction in obese individuals (Williams et al. 2002) . This has been further substantiated by studies demonstrating that weight loss reduces these risk factors (Knip & Nuutinen, 1993; ) and improves endothelial function in obese individuals (Raitakari et al. 2004) .
Methodological considerations and limitations
The velocity of CBF reflects regional CBF only if the conduit artery diameter is constant. Previous studies (Huber & Handa, 1967; Bradac et al. 1976; Serrador et al. 2000) demonstrated that the diameter of the MCA does not change significantly during moderate changes in arterial blood pressure and P ET,CO 2 in plasma, thus changes in CBV reflect changes in CBF and can be used as an index of cerebral perfusion. More recently, it has been reported that the diameter of the MCA increases during a magnitude of hypercapnia similar to that achieved in the present protocol (Coverdale et al. 2014; Verbree et al. 2014) . The magnitude of rebreathing-induced hypercapnia was similar between subject cohorts (Table 3 ; P = 0.82) in the present study. Furthermore, obesity impairs the vasodilatory capacity to a variety of perturbations in peripheral vascular beds (Perticone et al. 2001) ; therefore, it could be speculated that if there was dilatation of the MCA, the magnitude would be attenuated in the obese participants. If this were the case, the group differences in the present protocol would be underestimated. In this regard, it was recently demonstrated, using magnetic resonance imaging, that the degree of hypercapnia-induced vasodilatation of the MCA was blunted in aged individuals relative to young individuals (Coverdale et al. 2017) .
Previous studies that adopted a four-parameter logistic regression for the analysis of the CBF response to changing P aCO 2 included both hyperventilation-induced hypocapnic and rebreathing-induced hypercapnic periods (Claassen et al. 2009 ). However, the present study included only rebreathing-induced hypercapnia because recent research (Brothers et al. 2014) reported that hyperventilation-induced hypocapnia attenuates the cerebral vasodilatory responses during a subsequent period of rebreathing-induced hypercapnia. In order to assess the cerebral vasodilatory response without confounding factors caused by a preceding hypocapnic stage, hypocapnia-induced cerebral vasoconstriction was not assessed in the present investigation.
The P ET,CO 2 was used as an index of P aCO 2 . The P ET,CO 2 is correlated well with P aCO 2 at rest (Phan et al. 1987) or during hypercapnia (Xie et al. 2006) . Thus, we believe that P ET,CO 2 is an acceptable index for representing P aCO 2 both at rest and during hypercapnia.
As regional differences in responsiveness to alterations in P aCO 2 have been demonstrated previously (Sato et al. 2012 ), the present findings can be applied only to the vasculature supplying the cerebrum. Future work is needed to determine differences in reactivity in the posterior (i.e. basilar artery) circulation.
Conclusions and perspectives
Despite having a preserved CBF response (as indexed by CBV in the middle cerebral artery), secondary to an augmented pressor response, obese individuals had an attenuated increase in cerebral vascular conductance during hypercapnia when compared with lean individuals even though they were young (19-32 years old) and otherwise healthy. This finding indicates that cerebral vasodilatation, i.e. cerebral vascular reactivity, is impaired in otherwise healthy obese individuals. This may provide insight into the greater risk of cardiovascular and cerebral vascular disease that accompanies obesity (Gustafson et al. 2003; Gorospe & Dave, 2007; Mozaffarian et al. 2015) .
